28 June 2017
News and Views
Links and Services
A study published ahead of print in the Alimentary Pharmacology & Therapeutics identifies factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.
The safety of anti-tumour necrosis factor (TNF) agents during pregnancy is a major concern for ch
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors